Williams Syndrome, a rare neurodevelopmental disorder that affects about one in 10,000 babies born in the United States, produces a range of symptoms including cognitive impairments, cardiovascular problems, and extreme friendliness, or hypersociability.
Bausch + Lomb to initiate clinical trials for Technolas Teneo excimer laser
Bausch + Lomb will begin a clinical trial series of its Technolas Teneo excimer laser for vision correction surgery, the company announced in a press release.Designed to correct myopia and myopic astigmatism, the Technolas Teneo laser system is the sam…
FDA approves generic loteprednol etabonate from Akorn
The FDA has approved an abbreviated new drug application for Akorn’s loteprednol etabonate ophthalmic suspension 0.5%, according to a press release.“This is a really exciting approval for Akorn as we believe it is a first generic approval for lotepredn…
Global Ophthalmology Therapeutics Market 2019-2023| Development of Novel Drug Delivery Systems to Boost Growth| Technavio
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Research?src=hash" target="_blank"gt;#Researchlt;/agt;–The global ophthalmology therapeutics market will post a CAGR of close to 6% during the period 2…
Global Ophthalmic Lens Market 2019-2023| Increasing Adoption of Daily Disposable Contact Lenses to Boost Growth| Technavio
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Research?src=hash" target="_blank"gt;#Researchlt;/agt;–The global ophthalmic lens market will post a CAGR of close to 5% during the period 2019-2023
Wearable Epinephrine Injector to Stop Allergic Reactions
People susceptible to acute allergic reactions, particularly children, can find it difficult to keep an epinephrine injector (think EpiPen) on hand. Adrenaline, the common name of epinephrine, has to be delivered quickly before anaphylactic shock sets in, so a team at Rice University have developed a wearable injector that can be used at any time. (Read more...)